UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036649
Receipt number R000041750
Scientific Title Safety and feasibility study of fetal cardiac intervention for critical aortic stenosis
Date of disclosure of the study information 2019/05/08
Last modified on 2022/05/05 23:23:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and feasibility study of fetal cardiac intervention for critical aortic stenosis

Acronym

Feasibility study of fetal intervention for critical aortic stenosis

Scientific Title

Safety and feasibility study of fetal cardiac intervention for critical aortic stenosis

Scientific Title:Acronym

Feasibility study of fetal intervention for critical aortic stenosis

Region

Japan


Condition

Condition

critical aortic stenosis

Classification by specialty

Cardiology Obstetrics and Gynecology Pediatrics
Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and feasibility of fetal cardiac intervention for critical aortic stenosis.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The rates of completing protocol therapy without severe adverse events

Key secondary outcomes

The number and grade of adverse events by protocol therapy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Fetal aortic valvuloplasty for critical aortic stenosis

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

45 years-old >

Gender

Female

Key inclusion criteria

[Maternal criteria]
Between 22+0 and 31+6 weeks gestation
Pregnant women who have no severe complication or symptom of preterm labor
[Fetal criteria]
Fetal critical aortic stenosis without small left ventricle
Z score of LV long-axis dimension >-2
Threshold score 4 or 5
No other severe anomalies

Key exclusion criteria

Pregnant women who have infectious diseases required treatments
Pregnant women who have severe psychological disorder
American Society of Anesthesiology (ASA) Physical Status Classification Class 3, 4, 5 or 6
Multiple pregnancy
Severe obesity (BMI >35)

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Haruhiko
Middle name
Last name Sago

Organization

National Center for Child Health and Development

Division name

Center for Maternal-fetal, Neonatal and Reproductive Medicine

Zip code

157-8535

Address

2-10-1 Okura, Setagaya, Tokyo, Japan

TEL

03-3416-0181

Email

sagou-h@ncchd.go.jp


Public contact

Name of contact person

1st name Seiji
Middle name
Last name Wada

Organization

National Center for Child Health and Development

Division name

Division of Fetal Medicine

Zip code

157-8535

Address

2-10-1 Okura, Setagaya, Tokyo, Japan

TEL

03-3416-0181

Homepage URL

https://www.jsfc.jp/treatment/index.html

Email

wada-s@ncchd.go.jp


Sponsor or person

Institute

Japanese Society of Fetal Cardiology

Institute

Department

Personal name



Funding Source

Organization

National Center for Child Health and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

The Japan Society of Fetal Therapy
Japanese Society of Pediatric Cardiology and Cardiac Surgery

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

IRB in National Center for Child Health and Development

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535, Japan

Tel

03-3416-0181

Email

rinken@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立成育医療研究センター(東京都)
National Center for Child Health and Development (Tokyo, Japan)


Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 08 Day


Related information

URL releasing protocol

https://www.jsfc.jp/treatment/index.html

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 12 Month 25 Day

Date of IRB

2015 Year 03 Month 06 Day

Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date

2025 Year 02 Month 28 Day

Date of closure to data entry

2025 Year 03 Month 31 Day

Date trial data considered complete

2025 Year 06 Month 30 Day

Date analysis concluded

2025 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2019 Year 05 Month 04 Day

Last modified on

2022 Year 05 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041750


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name